| Literature DB >> 28470180 |
Agnieszka Kepa1,2, Lourdes Martinez Medina1,2, Susanne Erk3, Deepak P Srivastava1,4, Alinda Fernandes1, Roberto Toro5,6, Sabine Lévi7,8,9, Barbara Ruggeri1,2, Cathy Fernandes1,2, Franziska Degenhardt10, Stephanie H Witt11, Andreas Meyer-Lindenberg12, Jean-Christophe Poncer7,8,9, Jean-Luc Martinot13,14,15, Marie-Laure Paillère Martinot13,14,15,16, Christian P Müller17, Andreas Heinz3, Henrik Walter3, Gunter Schumann1,2, Sylvane Desrivières1,2.
Abstract
The fundamental role of the brain-specific myelin transcription factor 1-like (MYT1L) gene in cases of intellectual disability and in the etiology of neurodevelopmental disorders is increasingly recognized. Yet, its function remains under-investigated. Here, we identify a network of helix-loop-helix (HLH) transcriptional regulators controlled by MYT1L, as indicated by our analyses in human neural stem cells and in the human brain. Using cell-based knockdown approaches and microarray analyses we found that (1) MYT1L is required for neuronal differentiation and identified ID1, a HLH inhibitor of premature neurogenesis, as a target. (2) Although MYT1L prevented expression of ID1, it induced expression of a large number of terminal differentiation genes. (3) Consistently, expression of MYT1L in the human brain coincided with neuronal maturation and inversely correlated with that of ID1 and ID3 throughout the lifespan. (4) Genetic polymorphisms that reduced expression of MYT1L in the hippocampus resulted in increased expression of ID1 and ID3, decreased levels of the proneural basic HLH (bHLH) transcriptional regulators TCF4 and NEUROD6 and decreased expression of genes involved in long-term potentiation and synaptic transmission, cancer and neurodegeneration. Furthermore, our neuroimaging analyses indicated that MYT1L expression associated with hippocampal volume and activation during episodic memory recall, as measured by blood-oxygen-level-dependent (BOLD) signals. Overall, our findings suggest that MYT1L influences memory-related processes by controlling a neuronal proliferation/differentiation switch of ID-bHLH factors.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28470180 PMCID: PMC5549840 DOI: 10.1038/npp.2017.91
Source DB: PubMed Journal: Neuropsychopharmacology ISSN: 0893-133X Impact factor: 7.853